Inc. Has $21469000 Stake in CVS Health Corp (CVS)

Cornelia Mascio
Mag 20, 2017

Sussman Andrew also sold $1.13 million worth of CVS Health Corp (NYSE:CVS) shares. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator's stock worth $1,003,000 after buying an additional 40 shares in the last quarter. $4.90 million worth of CVS Health Corp (NYSE:CVS) was sold by Roberts Jonathan C on Thursday, February 16. Arcadia Investment Management Corp MI now owns 1,700 shares of the pharmacy operator's stock valued at $151,000 after buying an additional 95 shares in the last quarter. Elgethun Capital Management acquired a new position in shares of CVS Health Corp during the fourth quarter worth about $133,000.

Analysts give CVS a mean recommendation of 2.00. Independent Investors Inc. now owns 6,020 shares of the pharmacy operator's stock worth $535,000 after buying an additional 20 shares in the last quarter. 492,045 are owned by Institutional Cap Ltd Limited Liability Company.

Shares of CVS Health Corp (NYSE:CVS) opened at 76.62 on Friday. The fund owned 79,083 shares of the pharmacy operator's stock after selling 257 shares during the period. Haverford has 2.14% invested in CVS Health Corp (NYSE:CVS). Inc.'s holdings, making the stock its 26th largest position.

Strategic Financial Services Inc increased Cvs Health Corporation (CVS) stake by 49.92% reported in 2016Q4 SEC filing. The Average Volume of the company is 6.33 Million and P/E (price to earnings) ratio is 15.89, while Forward P/E ratio is 12.02. Cvs Health Corp now has $75.31 billion valuation. Southpoint Cap LP has invested 1.46% in CVS Health Corp (NYSE:CVS). After $0.88 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Traders may also be following some financial ratios for CVS Health Corporation (NYSE:CVS). That value represents a market adjusting for revenues that have been growing by 3.01 % on a quarterly year/year basis as of the company's last quarterly report. Analysts are forecasting earnings of $1.31 on a per share basis this quarter. The business's revenue for the quarter was up 3.0% compared to the same quarter a year ago.

The firm also recently declared a quarterly dividend, which was paid on Monday, May 1st. Proshare Advsrs Limited Liability Corporation invested in 0.12% or 137,793 shares. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is now sitting at 10. The ex-dividend date of this dividend was Wednesday, April 19th. Looking further, CVS Health Corporation has a Gross Margin score of 5.

Several research analysts have recently issued reports on the stock.

After a look at recent stock performance, CVS Health Corporation (NYSE:CVS) shares have traded $-3.1151 off of the 50-day moving average of $79.4352 and $-2.8963 off of the 200-day moving average of $79.2164. Tigress Financial assumed coverage on shares of CVS Health Corp in a report on Thursday, April 27th. Watching a firm's EV may be useful when comparing companies with different capital structures. Robert W. Baird cut CVS Health Corp from an "outperform" rating to a "neutral" rating and decreased their target price for the stock from $86.00 to $77.00 in a research note on Thursday, February 2nd. Jefferies Group LLC set a $82.00 price objective on shares of CVS Health Corp and gave the stock a "hold" rating in a research note on Saturday, April 1st. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has "Buy" rating by Argus Research on Monday, August 10.

In related news, EVP Troyen A. Brennan sold 23,849 shares of the stock in a transaction that occurred on Tuesday, March 21st. The shares were sold at an average price of $80.68, for a total transaction of $7,714,460.24. Following the transaction, the executive vice president now owns 41,614 shares of the company's stock, valued at $3,312,474.40. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The shares were sold at an average price of $80.40, for a total transaction of $1,133,961.60. The disclosure for this sale can be found here. In the last three months, insiders sold 139,600 shares of company stock valued at $11,205,962.

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Firm provides pharmacy care for the senior community through Omnicare, Inc. and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. The company was downgraded on Monday, February 6 by Atlantic Securities.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE